Website Preloader

Strategies to enhance the provider and patient EAP experience

7 Apr 2026 | By Uniphar
Reform of EU Pharmaceutical Legislation - Where Do We Stand?

Download our white paper: Strategies to enhance the provider and patient EAP experience

Expanded Access Programs (EAPs) play a multifaceted role in the drug development life cycle, acting as a critical bridge between clinical trials and commercial availability.

They provide a vital pathway for patients with unmet medical needs while offering valuable real-world insights. However, delivering a successful EAP requires clear communication, seamless coordination, and a patient centric approach.

In this white paper, explore strategies to:

•             Close awareness gaps by ensuring HCPs receive the right information at the right time

•             Simplify enrollment through clear processes and digital tools that reduce complexity

•             Build trust through continuity with a consistent, end-to-end EAP approach

•             Strengthen operational efficiency while enhancing patient outcomes

Download the white paper to discover how an end-to-end, single-provider approach can enhance stakeholder experience, reduce complexity, and strengthen the overall impact of your EAP strategy.